Skip to content
Search

Latest Stories

Increased cooperation among countries needed to regulate online pharmacies, says FIP report

Increased cooperation between countries is needed to ensure better regulation of online pharmacies, said authors of a new report – ‘Online pharmacy operations and distribution of medicines’, published by the International Pharmaceutical Federation’s (FIP) Community Pharmacy Section.

The report presents findings of a global survey of pharmacy organisations covering various aspects, such as type of medicines supplied by these pharmacies in different countries, how the authenticity of online pharmacies can be verified, and the usage of e-prescriptions and shared patient health records.


Of the 79 countries responding to the survey, 51 per cent acknowledged that no regulation of online pharmacies exists.

A quarter of the respondents reported cases of irresponsible self-medication by consumers who had purchased medicines through online pharmacies.

A lack of regulation creates “an avenue for illegal pharmacies and may impact the overall quality of medicines and services offered to consumers,” authors of the report said.

Lars-Åke Söderlund, immediate past president of FIP’s Community Pharmacy Section and co-editor of the report, said that the pandemic has increased preference for online services, including in the pharmacy sector.

Therefore, “It is important for health professionals to ensure consumers are informed and empowered to make good decisions related to the use of online pharmacies.”

He added that community pharmacists in most countries do not have access to digital health records, which acts as a barrier to achieve optimal patient care.

FIP CEO Dr Catherine Duggan said: “Consumers are increasingly wanting convenience, innovation and personalisation. This challenges pharmacists to provide a positive face-to-face experience for consumers utilising online channels.

“Nevertheless, digital transformation is critical and is an opportunity for pharmacies to further reinforce their place at the heart of their communities, with appropriate investment.”

More For You

Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less
After US and EU, UK approves Bavarian Nordic’s chikungunya vaccine

Bavarian Nordic plans to launch the vaccine in the UK in summer 2025

Getty Images

Chikungunya vaccine Vimkunya approved for use in the UK

The Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for Vimkunya, a vaccine developed by Bavarian Nordic A/S to prevent chikungunya disease in people aged 12 years and older.

The UK approval follows earlier approvals by the U.S. Food and Drug Administration (FDA) and the European Commission in February 2025, making this the third regulatory green light for the vaccine.

Keep ReadingShow less
NICE approves once-daily tablet Linzagolix for endometriosis

NICE recommends Linzagolix with add-back therapy for endometriosis

Image credit: Getty Images

NICE approves new at-home treatment for endometriosis

The National Institute for Health and Care Excellence (NICE) has recommended Linzagolix (brand name Yselty), a once-daily tablet, as a new treatment option for endometriosis.

Developed by Theramex, Linzagolix is approved for use alongside hormonal add-back therapy in adults of reproductive age who have previously tried other medical or surgical treatments for the condition.

Keep ReadingShow less
Many patients report inaccuracies or missing details in their NHS medical records

Inaccurate information can result in serious harm or even death, warns Healthwatch England.

Image Credit: Getty Images

1 in 4 adults have spotted errors in their NHS medical records, survey finds

Healthwatch England has raised the alarm over the risks posed by inaccurate medical records as research reveals widespread errors in NHS patient information.

Commissioned by Healthwatch England and conducted by BMG Research, the survey polled a representative sample of 1,800 adults in England between 24 and 27 March 2025.

Keep ReadingShow less
RPS and HEIW extend independent prescribing learning programme for pharmacists in Wales

The programme is designed to support pharmacists delivering the Pharmacy Independent Prescribing Service in Wales.

gettyimages

Independent prescribing learning programme for pharmacists in Wales extended till 2028

The Royal Pharmaceutical Society (RPS) and Health Education and Improvement Wales (HEIW) have announced a three-year extension of their successful learning programme designed to support pharmacists delivering the Pharmacy Independent Prescribing Service (PIPS) in Wales.

Originally launched in 2024, the programme equips pharmacists with the essential knowledge, skills, and confidence needed to provide excellent patient care as independent prescribers.

Keep ReadingShow less